Literature DB >> 25385411

Rheumatoid arthritis: Methotrexate and bridging glucocorticoids in early RA.

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25385411     DOI： 10.1038/nrrheum.2014.197

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

Authors:  P Verschueren; D De Cock; L Corluy; R Joos; C Langenaken; V Taelman; F Raeman; I Ravelingien; K Vandevyvere; J Lenaerts; E Geens; P Geusens; J Vanhoof; A Durnez; J Remans; B Vander Cruyssen; E Van Essche; A Sileghem; G De Brabanter; J Joly; S Meyfroidt; K Van der Elst; R Westhovens
Journal:  Ann Rheum Dis       Date:  2014-10-30       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.